Pharmacogenomic Testing to Guide Antidepressant Use Beneficial in Major Depression

Pharmacogenomics testing to guide antidepressant use yields population health gains and reduces health system costs.

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,Canadian ,British ,Shahzad Ghanbarian ,University Of British Columbia ,Canadian Medical Association ,Healthday News ,Canadian Medical ,